| Literature DB >> 35093089 |
Reza Hajialibeigloo1, Yaser Moradi2, Hossein Habibzadeh1, Rahim Baghaei1, Vahid Alinejad3, Mohammad Namazi Nia4.
Abstract
BACKGROUND: Despite the importance of assessing COVID-19 patients' educational needs, there is currently no standard tool for a comprehensive assessment of these needs. The present study was aimed at developing a questionnaire to assess the educational needs of COVID-19 patients and determining its psychometric properties.Entities:
Keywords: COVID-19; Educational needs; Psychometrics; Questionnaire
Mesh:
Year: 2022 PMID: 35093089 PMCID: PMC8800303 DOI: 10.1186/s12955-022-01922-0
Source DB: PubMed Journal: Health Qual Life Outcomes ISSN: 1477-7525 Impact factor: 3.186
The results of the Kaiser–Meyer–Olkin (KMO) measure and the Bartlett's test of spherocity
| Kaiser–Meyer–Olkin measure of sampling adequacy | 0.919 | |
| Bartlett's test of sphericity | Approx. chi-square | 7990.503 |
| df | 946 | |
| Sig | 0.000 | |
Demographic characteristics of participants (n = 200)
| Characteristics | Categories | n (%) |
|---|---|---|
| Gender | Male | 75 (37.5) |
| Female | 125 (62.5) | |
| Marital status | Married | 159 (79.5) |
| Single | 41 (20.5) | |
| Education | Primary | 31 (15.5) |
| Secondary | 100 (50) | |
| Tertiary | 69 (34.5) | |
| Admission | Outpatient | 90 (45) |
| Inpatient | 110 (55) |
Fig. 1Scree plot of the exploratory factor analysis of COPENAQ
Total variance obtained based on the exploratory factor analysis (EFA)
| Component | Initial eigenvalues | Extraction sums of squared loadings | Rotation sums of squared loadings | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Cumulative % | % of variance | Total | Cumulative % | % of variance | Total | Cumulative % | % of variance | Total | |
| 1 | 50.136 | 50.136 | 18.049 | 50.136 | 50.136 | 18.049 | 25.532 | 25.532 | 9.191 |
| 2 | 60.394 | 10.258 | 3.693 | 60.394 | 10.258 | 3.693 | 49.499 | 23.967 | 8.628 |
| 3 | 65.624 | 5.230 | 1.883 | 65.624 | 5.230 | 1.883 | 61.349 | 11.851 | 4.266 |
| 4 | 69.076 | 3.452 | 1.243 | 69.076 | 3.452 | 1.243 | 69.076 | 7.726 | 2.782 |
The results of exploratory factor analysis (EFA) with varimax rotation
| Item no | Factors | |||
|---|---|---|---|---|
| Disease recognition and treatment follow-up | Prevention of infection transmission | Medication regimen | Psychological and physiological needs | |
| 1 | 0.648 | |||
| 2 | 0.679 | |||
| 3 | 0.739 | |||
| 4 | 0.651 | |||
| 5 | 0.655 | |||
| 1 | 0.438 | |||
| 2 | 0.764 | |||
| 3 | 0.787 | |||
| 4 | 0.822 | |||
| 5 | 0.837 | |||
| 6 | 0.792 | |||
| 7 | 0.674 | |||
| 8 | 0.596 | |||
| 9 | 0.542 | |||
| 10 | 00.693 | |||
| 11 | 0.428 | |||
| 12 | 0.674 | |||
| 1 | 0.558 | |||
| 2 | 0.605 | |||
| 3 | 0.570 | |||
| 4 | 0.531 | |||
| 5 | 0.492 | |||
| 1 | 0.481 | |||
| 2 | 0.741 | |||
| 3 | 0.810 | |||
| 4 | 0.703 | |||
| 5 | 0.671 | |||
| 6 | 0.683 | |||
| 7 | 0.718 | |||
| 8 | 0.711 | |||
| 9 | 0.698 | |||
| 10 | 0.748 | |||
| 11 | 0.702 | |||
| 12 | 0.814 | |||
| 13 | 0.854 | |||
| 14 | 0.831 | |||
Fig. 2Results from confirmatory factor analysis. A Disease recognition and treatment follow-up. B Prevention of infection transmission. C Medication regimen. D Psychological and physiological needs. Root mean square error of approximation (RMSEA) = 0.12, 90 percent confidence interval for RMSEA = (0.11; 0.12). P value for test of close fit (RMSEA < 0.05) = 0.0001
Cronbach’s alpha calculated for the whole questionnaire (COPENAQ) and its subscales
| Factors | Cronbach’s α coefficient |
|---|---|
| Disease recognition and treatment follow-up | 0.85 |
| Prevention of infection transmission | 0.94 |
| Medication regimen | 0.93 |
| Psychological and physiological needs | 0.96 |
| Total | 0.97 |
Items of the COPENAQ
| Subscale | No | Item | Not important at all | Slightly important | Moderately important | Very important | Extremely important |
|---|---|---|---|---|---|---|---|
| Disease recognition and treatment follow-up | 1 | What symptoms may be associated with my disease? | |||||
| 2 | What complications can happen to me following my disease? | ||||||
| 3 | What should I do if the disease symptoms (e.g., cough, shortness of breath, headache) worsen? | ||||||
| 4 | In what circumstances should I refer to a doctor/hospital again? | ||||||
| 5 | How is the disease transmitted to those around me? | ||||||
| Prevention of infection transmission | 6 | How should I isolate myself to prevent the disease transmission to my family members? | |||||
| 7 | How long is the minimum isolation period after discharge? | ||||||
| 8 | When should I definitely wash or sanitize my hands? | ||||||
| 9 | What is the exact method of handwashing to kill germs and viruses and how long should it be? | ||||||
| 10 | Which hand sanitizer is better for washing or sanitizing my hands? | ||||||
| 11 | When and how should I use gloves? | ||||||
| 12 | When should I use a face mask? | ||||||
| 13 | What kind of mask should I use? | ||||||
| 14 | How should I use a face mask? | ||||||
| 15 | What can I do to prevent the disease transmission in shared spaces of the house (e.g., bathroom, toilet)? | ||||||
| 16 | What should I do to prevent the disease transmission when coughing and sneezing? | ||||||
| 17 | What should I do to disinfect my resting place? | ||||||
| Medication regimen | 18 | How should I take my medications? | |||||
| 19 | When should I take my medications? | ||||||
| 20 | What is the reason for prescribing each of my medications? | ||||||
| 21 | What are the adverse effects of my medications and what should I do when they occur? | ||||||
| 22 | What should I do if I miss a dose of my medication? | ||||||
| Psychological and physiological needs | 23 | What foods should I consume and what foods should I avoid? | |||||
| 24 | Do I need to take certain dietary supplements (e.g. vitamins or multivitamins)? | ||||||
| 25 | How should I prepare the food I want to consume? | ||||||
| 26 | How should I deal with problems affecting my diet (e.g., nausea, vomiting, diarrhea, pain)? | ||||||
| 27 | How much should I rest during the day? | ||||||
| 28 | When can I return to work? | ||||||
| 29 | Does the treatment of this disease require any specific activity restrictions? | ||||||
| 30 | What should I do if I do not get regular sleep? | ||||||
| 31 | How can I control my restlessness and anxiety? | ||||||
| 32 | What can I do to overcome the sense of nostalgia during the isolation period? | ||||||
| 33 | How can I avoid aggression? | ||||||
| 34 | When can I have sex after discharge? | ||||||
| 35 | What important health points should I stick to in my sexual relationship? | ||||||
| 36 | Is my sexual partner (my spouse) at risk of contracting the disease through sexual intercourse? |